Georgia Bio Quarterly Meeting: State of the Industry Report

April 17, 2019 | 7:30 – 9:00AM
Upstairs Atlanta, 525 Bishop St NW, Atlanta, GA 30318

Join Georgia Bio for a preview of the 2019 Georgia Life Sciences Industry Analysis. This breakfast meeting will provide members, non-members and Georgia community leaders with valuable industry information.

The state of the industry report, supported by funding from the Biotechnology Innovation Organization (BIO), Georgia Department of Economic Development, Georgia Global Health Alliance, Georgia Research Alliance, Johnson & Johnson, PhRMA, UCB, Inc. and VWR, part of Avantor, features employment and economic contribution from Georgia’s life sciences industry. Georgia Bio CEO Maria Thacker-Goethe will deliver a summary and highlights from the report followed by a panel discussion featuring Georgia Lt. Governor Geoff Duncan, Georgia Research Alliance President & CEO Russell Allen and Head of U.S. Gov’t Relations for UCB Joseph Zorzoli.

“While we don’t want to let the cat out of the bag, it can suffice to say Georgia’s life science industry has shown strong growth compared to the national average and other industry sectors in the state,” Thacker-Goethe said. “We look forward to sharing the report and hosting a lively discussion with our distinguished panelists.”

Georgia Bio has long been a go-to source for data on the bioscience industry in our State. Do not miss this chance to network with industry leaders and learn about one of Georgia’s most innovative sectors. The full 2019 Georgia Life Sciences State of the Industry Report will be made public in the coming weeks.

Register here.

Those unable to attend can live stream the event on Georgia Bio’s Youtube channel.

The post Georgia Bio Quarterly Meeting: State of the Industry Report appeared first on Georgia Bio.

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.